Business
Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery
Press release – No. 5 / 2025 Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery Utpal joins Zealand Pharma at a pivotal moment as it aims to become a leader in the management of obesity and related complications He will lead the discovery and clinical translation of peptide medicines, investing in new technologies including data and computational science Utpal to expand the global scientific team to drive Zealand Pharma’s next
About this update from Zealand Pharma A/s
[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6gUCOEdJjLHihlE.VvDQtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Press release – No. 5 / 2025","length":28,"tagName":"p"},{"type":"text","content":"Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery","length":119,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Utpal joins Zealand Pharma at a pivotal moment as it aims to become a leader in the management of obesity and related complications","length":131,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":131,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"He will lead the discovery and clinical translation of peptide medicines, investing in new technologies including data and computational science","length":144,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":144,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Utpal to expand the global scientific team to drive Zealand Pharma’s next wave of highly differentiated, innovative therapies, building on the Company’s strong drug development heritage","length":185,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":185,"olType":false},{"type":"text","content":"Copenhagen, Denmark, 23 April 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the appointment of Utpal Singh as Chief Scientific Officer. Utpal will join the executive team to lead discovery research and translational sciences at Zealand Pharma.","length":394,"tagName":"p"},{"type":"text","content":"Utpal brings nearly 25 years of pharmaceutical industry experience spanning the full drug discovery and development lifecycle. Most recently, he served as Senior Vice President of Small Molecule Discovery at Eli Lilly...